Press Releases

Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
Arch Therapeutics to Provide Corporate Update at the 11th Annual LD Micro Main Event on Tuesday, December 4, 2018
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5™ Topical Gel
Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday, October 2, 2018
RSS
Show All